Microsphere formation in a subtype of Creutzfeldt–Jakob disease with a V180I mutation and codon 129 MM polymorphism
Article first published online: 28 OCT 2013
© 2013 British Neuropathological Society
Neuropathology and Applied Neurobiology
Volume 39, Issue 7, pages 844–848, December 2013
How to Cite
Honda, H., Ishii, R., Hamano, A., Itoh, K., Suzuki, S. O., Fushiki, S., Nakagawa, M. and Iwaki, T. (2013), Microsphere formation in a subtype of Creutzfeldt–Jakob disease with a V180I mutation and codon 129 MM polymorphism. Neuropathology and Applied Neurobiology, 39: 844–848. doi: 10.1111/nan.12047
- Issue published online: 28 OCT 2013
- Article first published online: 28 OCT 2013
- Accepted manuscript online: 26 MAR 2013 05:34AM EST
- Manuscript Accepted: 8 MAR 2013
- Manuscript Received: 2 OCT 2012
- Japan Society for the Promotion of Science (JSPS). Grant Number: 24650186
Figure S1. The distribution of PrP-positive microspheres. (A) Haematoxylin and eosin stain. (B, C, D) Immunohistochemistry for prion protein (clone 3F4). (E) Schema showing distribution of amyloid microspheres. Numerous microspheres are distributed at the layer of pre-α neurone (asterisks) in the transentorhinal cortex (A, B), in the molecular layer of the cerebellar cortex (C) and in the central grey matter of the midbrain (D). (E) Microspheres are widely distributed in the cerebral neocortices, entorhinal cortex and transentorhinal cortex, but focally detected in the molecular layer of the cerebellum.
Figure S2. Western blotting for PrP in brain homogenates prepared in lysis buffer with 1% sodium dodecyl sulphate. (A) In the sample without PK treatment, Western blotting using 3F4 antibody reveals nonglycoform, monoglycoform, diglycoform PrP bands. In addition, a PrP fragment around 15 kDa is also noted (arrow). (B) In the sample without PK treatment, the PrP fragment around 15 kDa is not detected by Western blotting using the 8H4 antibody. (C) In the fractionated sample (f3) with PK treatment, the fragment around 13 kDa is not detected by Western blotting using the 8H4 antibody. * (asterisks): loading sample.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.